AQR Capital Management’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $948K | Buy |
|
|||||
|
2025
Q1 | $462K | Buy |
|
|||||
|
2024
Q4 | $244K | Buy |
|
|||||
|
2024
Q3 | $84.3K | Buy |
|
|||||
|
2024
Q2 | $54K | Sell |
|
|||||
|
2024
Q1 | $162K | Sell |
|
|||||
|
2023
Q4 | $879K | Sell |
|
|||||
|
2023
Q3 | $706K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $1.55M | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $599K | Sell |
|
|||||
|
2021
Q4 | $1.57M | Sell |
|
|||||
|
2021
Q3 | $2.14M | Sell |
|
|||||
|
2021
Q2 | $3.31M | Buy |
|
|||||
|
2021
Q1 | $2.79M | Sell |
|
|||||
|
2020
Q4 | $3.21M | Sell |
|
|||||
|
2020
Q3 | $1.62M | Sell |
|
|||||
|
2020
Q2 | $1.7M | Sell |
|
|||||
|
2020
Q1 | $1.17M | Buy |
|
|||||
|
2019
Q4 | $374K | Sell |
|
|||||
|
2019
Q3 | $459K | Sell |
|
|||||
|
2019
Q2 | $609K | Sell |
|
|||||
|
2019
Q1 | $593K | Sell |
|
|||||
|
2018
Q4 | $498K | Sell |
|
|||||
|
2018
Q3 | $769K | Hold |
|
|||||
|
2018
Q2 | $535K | Buy |
|
|||||
|
2018
Q1 | $313K | Buy |
|